EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis

por Smonskey, Matthew, Lasorsa, Elena, Rosario, Spencer, Kirk, Jason S., Hernandez-Ilizaliturri, Francisco J., Ellis, Leigh
Publicado 2016

Breast Implant-Associated Anaplastic Large Cell Lymphoma (ALCL): A Case Report

por Evren, Sevan, Khoury, Thaer, Neppalli, Vishalla, Cappuccino, Helen, Hernandez-Ilizaliturri, Francisco J., Kumar, Prasanna
Publicado 2017

Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma

por Singh, Anil R., Gu, Juan J., Zhang, Qunling, Torka, Pallawi, Sundaram, Suchitra, Mavis, Cory, Hernandez-Ilizaliturri, Francisco J.
Publicado 2020

Pevonedistat, a NEDD8‐activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre‐clinical models of diffuse large B‐c...

por Torka, Pallawi, Mavis, Cory, Kothari, Shalin, Belliotti, Sarah, Gu, Juan, Sundaram, Suchitra, Barth, Matthew, Hernandez‐Ilizaliturri, Francisco J.
Publicado 2020

Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development

por Gu, Juan J., Singh, Anil, Xue, Kai, Mavis, Cory, Barth, Matthew, Yanamadala, Vivek, Lenz, Peter, Grau, Michael, Lenz, Georg, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.
Publicado 2017

Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy

por Goel, Shipra, Gu, Juan J., Torka, Pallawi, Mavis, Cory, Sundaram, Suchitra, Neiders, Mirdza, Suresh, Lakshmanan, Shen, Long, Ramsperger, Vince, Griffiths, Elizabeth A., Segal, Brahm, Hernandez-Ilizaliturri, Francisco J., Ghione, Paola
Publicado 2021

The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance

por Liu, Yizhen, Gu, Juan J., Yang, Ling, Tsai, Ping-Chiao, Guo, Ye, Xue, Kai, Xia, Zuguang, Liu, Xiaojian, Lv, Fangfang, Cao, Junning, Hong, Xiaonan, Mavis, Cory, Hernandez-Ilizaliturri, Francisco J., Zhang, Qunling
Publicado 2020

Immune profiling in Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma Patients treated with Autologous Hematopoietic Cell Transplant

por Herr, Megan M., Torka, Pallawi, Zhang, Yali, Wallace, Paul K., Tario, Joseph D., Repasky, Elizabeth A., Chen, George L., Ho, Christine M., Balderman, Sophia R., Ross, Maureen, Paiva, Bruno, Hernandez-Ilizaliturri, Francisco J., McCarthy, Philip L., Hahn, Theresa
Publicado 2019

Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status

por Lama, Rati, Xu, Chao, Galster, Samuel L., Querol-García, Javier, Portwood, Scott, Mavis, Cory K., Ruiz, Federico M., Martin, Diana, Wu, Jin, Giorgi, Marianna C., Bargonetti, Jill, Wang, Eunice S., Hernandez-Ilizaliturri, Francisco J., Koudelka, Gerald B., Chemler, Sherry R., Muñoz, Inés G., Wang, Xinjiang
Publicado 2022

Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study

por Gregory, Gareth P., Kumar, Shaji, Wang, Ding, Mahadevan, Daruka, Walker, Patricia, Wagner-Johnston, Nina, Escobar, Carolina, Bannerji, Rajat, Bhutani, Divaya, Chang, Julie, Hernandez-Ilizaliturri, Francisco J., Klein, Andreas, Pagel, John M., Rybka, Witold, Yee, Andrew J., Mohrbacher, Anne, Huang, Mo, Farooqui, Mohammed, Marinello, Patricia, Quach, Hang
Publicado 2022

Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL

por Torka, Pallawi, Groman, Adrienne, Wong, Jerry, Nichols, Jenna, Kader, Angela, Mavis, Cory, Anampa-Guzmán, Andrea, Sait, Sheila Jani, Block, AnneMarie, Przespolewski, Eugene, Mohr, Alice, Lund, Ian, McWhite, Kenneth, Kostrewa, Jessica, DeMarco, Joseph, Johnson, Michael, Darrall, Andrea, Thomas, Roshneke, Sundaram, Suchitra, Ghione, Paola, Hutson, Alan, Hernandez-Ilizaliturri, Francisco J.
Publicado 2022

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies

por Ghione, Paola, Gu, Juan J., Attwood, Kristopher, Torka, Pallawi, Goel, Shipra, Sundaram, Suchitra, Mavis, Cory, Johnson, Michael, Thomas, Roshneke, McWhite, Kenneth, Darrall, Andrea, DeMarco, Joseph, Kostrewa, Jessica, Mohr, Alice, Rivas, Leah, Neiders, Mirdza, Suresh, Lakshmanan, Segal, Brahm H., Griffiths, Elizabeth A., Ramsperger, Vince, Shen, Long, Hernandez-Ilizaliturri, Francisco J.
Publicado 2021

A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy

por Choi, Yun, Caro, Jessica, Li, Xiaochun, Al-Obeidi, Arshed, Kurtz, Sharyn Lynn, Kim, Austin I., Chang, Julie E., Olszewski, Adam J., Zayac, Adam, Matthews, Andrew, Barta, Stefan K., Sundaram, Suchitra, Hernandez-Ilizaliturri, Francisco J., Leslie, Lori A., Caimi, Paolo, Carter, Jordan, David, Kevin A., Evens, Andrew M., Kim, Myung Sun, Nagle, Sarah J., Goldberg, Judith, Diefenbach, Catherine S.
Publicado 2021